Enteral Zinc Supplementation in Very Low Birth Weight Infants

Launched by UNIVERSITY OF TENNESSEE · May 23, 2024

Keywords

ClinConnect Summary

This is a prospective, single center, randomized, double blinded, placebo controlled clinical trial. The goal of this clinical trial is to observe for changes in rate of weight gain in the VLBW infants by adding an enteral Zinc supplement of 1 mg/kg/day of elemental zinc. The main question it aims to answer:

• Does an enteral Zinc supplement of 1 mg/kg/day increase rate of weight gain in VLBW infants Researches will compare the experimental group to a placebo group to see if there is a statistical difference in rate of weight gain between the two groups

* Once the participants have reache...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Birth weight \< 1500 grams
• • 2. Infant is tolerating at least 100 ml/kg/day of enteral feeds
• • 3. At least 25wks PMA.
• Exclusion Criteria:
• • Major congenital malformations especially anomaly of the GI tract
• • Major congenital heart disease (i.e.: ductal dependent lesion)
• • Previously diagnosed necrotizing enterocolitis (stage 2 or 3), bowel perforation, or bowel resection
• • Infant who has tolerated ≥100 ml/kg/day prior to admission.

Trial Officials